Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
PRODIASYS2
1 other identifier
observational
440
1 country
10
Brief Summary
Sepsis induces a reversible systolic and diastolic cardiac dysfunction. The presence of a left ventricular (LV) diastolic dysfunction during septic shock could favor harmful volume overload. Recently, a meta-analysis suggested a negative prognostic role of LV diastolic dysfunction in septic patients (Od Ratio: 1.82; 95%CI: 1.12 - 2.97; p = 0.02) but its external validity is hampered by the numerous limits and the heterogeneity of the studies. To date, a pathophysiological link between LV diastolic dysfunction associated with septic shock and the water balance (reflecting volume overload) remains to establish. In addition, small size studies reported an excess of mortality in patients with septic shock who were diagnosed with a high cardiac output. However, no large cohort has yet confirmed the negative prognostic role of a hyperkinetic hemodynamic profile at the initial phase of septic shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Typical duration for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2016
CompletedFirst Posted
Study publicly available on registry
September 28, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedMarch 19, 2026
March 1, 2026
2.7 years
September 27, 2016
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival
Survival at one month
Day 28
Secondary Outcomes (2)
Daily water balance
Day 1 to Day 3
Cumulated water balances
Day 4
Study Arms (1)
echocardiography
Each patient will be hemodynamically assessed using echocardiography: Day1 defines the first echocardiography performed within the first 12 hours (ideally within the first 6 h) following the diagnosis of septic shock, Day2 and Day3 define the examination performed 24 to 36 h and 48 to 72 h later (guidance of treatment during the acute phase), Day end defines the examination performed after vasopressors cessation (end of hemodynamic failure). In addition, echocardiography will be performed on ICU discharge and on Day28 or on hospital discharge (whatever occurs first) to document potential reversibility of LV diastolic dysfunction. Transthoracic echocardiography will always first be performed and transesophageal echocardiography will be limited to ventilated patients without adequate surface echocardiographic image quality, under sedation and during the initial phase of septic shock (D1 to D3), according to the standards of care of participating centers.
Eligibility Criteria
Patients will be recruited in the ICU but also in Emergency Departments if they present with septic shock before ICU admission
You may qualify if:
- Patient hospitalized in ICU for septic shock:
- Documented or highly suspected infection (clinically or microbiologically)
- Causing an organ failure defined as an acute change in total SOFA score ≥ 2 points (baseline SOFA score can be assumed to be zero in the absence of pre-existing organ dysfunction)
- And low blood pressure (sBP \< 90 mmHg or a decrease of more than 40 mmHg compared to baseline, or mBP \< 65 mmHg) despite a fluid loading of 30 mL/kg (except if clinical or radiological sign of pulmonary fluid overload) requiring vasopressor infusion to maintain mBP \> 65 mmHg
- And lactate level \> 2 mmol/L
- Patient older than 18 years old affiliated to the French Social Security
- Non-opposition of the patient (or of its next-of-kin) to participate in the study
You may not qualify if:
- Ongoing dobutamine or epinephrine infusion
- Severe left valvular disease (severe stenosis, severe regurgitation ≥ grade 3)
- Constrictive pericarditis (invalidate the mitral tissue Doppler imaging)
- Pregnant women
- Patient with estimated life expectancy \< 24h.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Limogeslead
- University Hospital, Tourscollaborator
Study Sites (10)
University Hospital
Amiens, 80000, France
University Hospital
Brest, 29200, France
University Hospital
Limoges, 87042, France
CHU de Nancy
Nancy, 54511, France
CH d'Orleans
Orléans, 45000, France
Aphp - Ambroise Paré
Paris, 75010, France
CHU de Poitiers
Poitiers, 86021, France
Felix Guyon Hospital
Saint-Denis, 97405, France
University Hospital
Toulouse, 31000, France
University Hospital
Tours, 37000, France
Related Publications (1)
Vignon P, Charron C, Legras A, Musset F, Slama M, Prat G, Silva S, Vandroux D, Muller G, Levy B, Boissier F, Evrard B, Goudelin M, Mankikian S, Nay MA, Jabot J, Riu B, Bailly P, Maizel J, Leger J, Vieillard-Baron A; CRICS-TRIGGERSEP Network. Left ventricular diastolic dysfunction is prevalent but not associated with mortality in patients with septic shock. Intensive Care Med. 2025 Jan;51(1):94-105. doi: 10.1007/s00134-024-07748-2. Epub 2025 Jan 7.
PMID: 39774865RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marine GOUDELIN, MD
University Hospital, Limoges
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2016
First Posted
September 28, 2016
Study Start
January 1, 2017
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share